Article

A systematic review of the epidemiology of status epilepticus.

Institute of Child Health, University College London, London, UK and Great Ormond Street Hospital for Children NHS Trust, London WCIN IEH, UK.
European Journal of Neurology (impact factor: 3.69). 01/2005; 11(12):800-10. DOI:10.1111/j.1468-1331.2004.00943.x pp.800-10
Source: PubMed

ABSTRACT Population-based data on the incidence, aetiology, and mortality associated with status epilepticus (SE) are required to develop preventative strategies for SE. Through a systematic review, we aimed to assess the methodological quality as well as similarities, and differences between available population based studies in order to arrive at conclusions on the epidemiology of SE. All population-based studies where primary outcome was incidence, aetiology or mortality of SE were identified through a systematic search and synthesized. Methodological quality of studies were independently rated by two examiners using a unique scoring system. Seven population-based projects on SE yielding nine published reports and five abstracts were reviewed. Quality scores were in the range of 19-34 with a possible maximum of 40 (kappa scores 0.67-1.0). The incidence of SE has a bimodal distribution with peaks in children aged less than a year and the elderly. Most SE were acute symptomatic. Short-term mortality was 7.6-22% and long-term mortality was 43%. Age and aetiology were the major determinants of mortality. There are few population-based studies on SE but most are of good quality. Most studies are primarily or exclusively based on adult populations. There is limited information on the association of ethnicity and socio-economic status and SE.

0 0
 · 
0 Bookmarks
 · 
34 Views
  • Article: Epilepsy emergencies: diagnosis and management.
    [show abstract] [hide abstract]
    ABSTRACT: Seizures and status epilepticus are epilepsy emergencies with high morbidity and mortality. Early treatment is crucial, and the identification of an underlying etiology informs both continued treatment and prognosis. Many patients have underdiagnosed nonconvulsive seizures or nonconvulsive status epilepticus, particularly the comatose or critically ill. Timely EEG can be useful for diagnosis, management, optimizing treatment response, and determining prognosis in these patients. Refractory conditions can be quite complicated with limited evidence-based guidance, but treatment should not be restricted by nihilism even in the most prolonged cases, especially if there is not widespread irreversible brain injury.
    Neurologic Clinics 02/2012; 30(1):11-41, vii. · 2.34 Impact Factor
  • Article: Verapamil attenuates the malignant treatment course in recurrent status epilepticus.
    [show abstract] [hide abstract]
    ABSTRACT: In the scenario of refractory status epilepticus, the recommended approach of intensive care treatment is limited with respect to the available pharmacodynamic variability and its impeding, severe side effects. Alternative treatment options are therefore urgently needed. In the case described, a patient with nonlesional frontal lobe epilepsy had a high-frequency series of tonic seizures, which evolved into a malignant form of status epilepticus. Co-administration of verapamil, a potent multidrug transporter inhibitor, was followed by significant reduction in seizure frequency. We discuss the putative role of verapamil and the specific risk factors for this malignant treatment course.
    Epilepsy & Behavior 02/2010; 17(4):565-8. · 2.34 Impact Factor
  • Source
    Article: An observational electro-clinical study of status epilepticus: from management to outcome.
    [show abstract] [hide abstract]
    ABSTRACT: Status epilepticus (SE) is a neurological emergency associated with a high morbidity and mortality. A prospective 3-year study was conducted in our hospital on 56 consecutive inpatients with SE. Demographic and clinical data were collected. EEG and clinical SE features were considered for the SE classification, both separately and together. The etiology of SE was determined. Patients were treated according to international standardized protocols of guidelines for the management of epilepsy. Response to treatment was evaluated clinically and electrophysiologically. Outcome at 30 days was considered as good, poor or death. Convulsive SE (CSE) was observed in 35 patients and non-convulsive SE (NCSE) in 21. Patients with CSE, in particular focal-CSE, were older than those with NCSE. As regards etiology, patients with SE secondary to cerebral lesions were the oldest, followed by patients with anoxic SE and those with toxic dysmetabolic SE. A first-line treatment was usually sufficient to control seizure activity in lesional and epileptic SE, while more aggressive treatment was necessary in all anoxic SE patients. Outcome was good in 35 patients, poor in 12, while 9 died. A prompt neurophysiological EEG evaluation, combined with the clinical evaluation, helps to make a rapid prognosis and take therapeutic management decisions. First-line treatments may be sufficient to control electro-clinical status in lesional and epileptic SE, while intensive care unit management, a more aggressive therapeutic approach and continuous EEG monitoring are recommended for refractory SE.
    Seizure 03/2012; 21(2):98-103. · 1.80 Impact Factor

Full-text

View
0 Downloads

Keywords

adult populations
 
available population
 
bimodal distribution
 
good quality
 
long-term mortality
 
major determinants
 
Methodological quality
 
Population-based data
 
population-based projects
 
population-based studies
 
possible maximum
 
preventative strategies
 
primary outcome
 
Quality scores
 
Short-term mortality
 
socio-economic status
 
status epilepticus
 
systematic review
 
systematic search
 
unique
 

R F M Chin